1 From the Departments of Medicine, Pediatrics, and Laboratory Medicine, University of Washington; Children's Orthopedic Hospital and Medical Center; and the Mason Clinic, Seattle
During a 12-month period, 14 patients with the hemolytic uremic syndrome were identified in a prospective study of enteric pathogens associated with this disorder. Of the 12 patients with a diarrheal illness preceding the onset of hemolytic uremic syndrome, fecal Escherichia coli O157:H7 was detected in seven (58%), all of whom had bloody diarrhea. Half of the siblings of these patients had concurrent nonbloody diarrhea. No source for infection with this organism was identified. Enteric infection with E coli O157:H7 occurs in the majority of cases of hemolytic uremic syndrome following diarrheal illness in the Pacific Northwest and may represent a previously overlooked cause of hemolytic uremic syndrome in other locales. Evaluation of all cases of hemolytic uremic syndrome for enteric pathogens should routinely include cultures for E coli O157:H7 until results of additional studies clarify the distribution of agents associated with hemolytic uremic syndrome in different geographic regions. These findings may provide new opportunities for the design of therapeutic and preventive strategies in this disorder.
Key Words: hemolytic uremic syndrome Escherichia coli O157:H7 hemorrhagic colitis verotoxin acute renal failure
Accepted on October 23, 1986
This article has been cited by other articles:
![]() |
M. C. Pearce, D. Fenlon, J. C. Low, A. W. Smith, H. I. Knight, J. Evans, G. Foster, B. A. Synge, and G. J. Gunn Distribution of Escherichia coli O157 in Bovine Fecal Pats and Its Impact on Estimates of the Prevalence of Fecal Shedding Appl. Envir. Microbiol., October 1, 2004; 70(10): 5737 - 5743. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-S. Rhee, S.-Y. Lee, R. H. Dougherty, and D.-H. Kang Antimicrobial Effects of Mustard Flour and Acetic Acid against Escherichia coli O157:H7, Listeria monocytogenes, and Salmonella enterica Serovar Typhimurium Appl. Envir. Microbiol., May 1, 2003; 69(5): 2959 - 2963. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Konadu, A. Donohue-Rolfe, S. B. Calderwood, V. Pozsgay, J. Shiloach, J. B. Robbins, and S. C. Szu Syntheses and Immunologic Properties of Escherichia coli O157 O-Specific Polysaccharide and Shiga Toxin 1 B Subunit Conjugates in Mice Infect. Immun., November 1, 1999; 67(11): 6191 - 6193. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Boyce, D. L. Swerdlow, and P. M. Griffin Escherichia coli O157:H7 and the Hemolytic-Uremic Syndrome N. Engl. J. Med., August 10, 1995; 333(6): 364 - 368. [Full Text] [PDF] |
||||
![]() |
E. COLI IS A CAUSE OF HEMOLYTIC UREMIC SYNDROME Journal Watch (General), August 11, 1987; 1987(811): 6 - 6. [Full Text] |
||||